{{Rsnum
|rsid=6505469
|Gene=NOS2
|Chromosome=17
|position=27784860
|Orientation=plus
|GMAF=0.4238
|Gene_s=NOS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 25.7 | 49.6 | 24.8
| HCB | 20.4 | 43.1 | 36.5
| JPT | 15.0 | 55.8 | 29.2
| YRI | 74.1 | 25.9 | 0.0
| ASW | 66.7 | 29.8 | 3.5
| CHB | 20.4 | 43.1 | 36.5
| CHD | 9.3 | 53.7 | 37.0
| GIH | 54.0 | 37.0 | 9.0
| LWK | 72.7 | 25.5 | 1.8
| MEX | 0.0 | 0.0 | 0.0
| MKK | 72.9 | 24.5 | 2.6
| TSI | 27.5 | 52.0 | 20.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=24379293
|Title=NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection and cerebral malaria
}}

{{on chip | Affy GenomeWide 6}}